Skip to main content
. Author manuscript; available in PMC: 2014 May 23.
Published in final edited form as: J Med Chem. 2013 May 13;56(10):4116–4124. doi: 10.1021/jm4004494

Table 2.

Antimicrobial and Binding Properties

MIC (μg/mL) Association constant for 3
Compound S. aureusa E. faecalisb (VanB) Ka, M−1 (× 105)c Δ Δ G b d
Vancomycin (1) 1.25 120 1.8 (2.3–3.9)e
Vancomycin Aglycon (2) 1.25 40 1.4 -
16 (-Br) 2.5 40 1.1 0.14
29 (-OH) 5 40 0.53 0.57
30 (-H) 5 80 0.68 0.42
Permethyl Aglycon Derivatives
7 (-Cl) 1.25 2.5 1.3 (2.0) -
11b (-B(OH)2) 5 10 0.23 1.03
14b (-Br) 2.5 5 1.1 0.1
18b (-NMe2) 5 10 0.34 0.79
19b (-N3) 1.25 5 1.2 0.05
20b (-NO2) >40 >40 0.097 1.56
21b (-CO2CH3) 2.5 10 1.0 0.16
22b (-I) 2.5 10 1.3 0
23b (-OMe) 2.5 5 1.2 0.05
24b (-CN) 2.5 5 1.1 0.1
25b (-H) 5 5 0.71 0.36
26b (-OH) 5 5 0.88 0.23
27b (-CH3) 2.5 5 1.2 0.05
28b (-CF3) 2.5 20 1.2 0.05
a

Vancomycin-sensitive Staphylococcus aureus (ATCC 25923).

b

Vancomycin-resistant Enterococcus faecalis (VanB, ATCC 51299).

c

Binding to N,N′ -Ac2-L-Lys-D-Ala-D-Ala (3).

d

The free energy of binding (ΔΔGb) was tabulated from the experimentally determined Ka using the equation ΔΔGb = RTlnK, where K=1Ka/xKa; 1Ka is the association constant for the complex of 2 or 8 with 3; xKa is the association constant for the complex of compound X with 3.

e

Taken from ref 8a.